Company

The founding of targomed® in 2010 was not so long ago, but we have been able to contribute experience from the pharmaceutical and medical device industry since 1988.

 

Versatility is our strength

We are a specialized partner for medical-scientific projects with a strong focus on ophthalmology, supporting clinical studies with medical devices from initial concept through to final publication. At the core of our work is a flexible, modular service approach that provides tailored support across all phases of a project.

Our expertise includes strategic consulting—particularly in Post-Market Clinical Follow-Up (PMCF)—as well as the application of advanced digital solutions such as our proprietary EDC system targoDoc and a dedicated PMCF portal.

Our interdisciplinary team manages full or selected aspects of clinical study operations, from study concept development and documentation to coordination with investigative sites, sponsors and regulatory authorities, as well as monitoring, data management and statistical analysis. This portfolio is complemented by professional medical writing services, including clinical study reports, regulatory documentation and scientific publications and conference contributions.

What defines our work are structured processes, deep scientific expertise and an uncompromising commitment to quality—ensuring robust clinical evidence and smooth project execution.

More about targomed®: